Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Brain Tumors
NCT00576537Phase 2Completed
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Mar 2001
- Primary completion
- Oct 2011
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of autologous tumor lysate-pulsed dendritic cells in brain tumor, glioblastoma (GBM), sponsored by Cedars-Sinai Medical Center. Started Mar 2001; status: completed.
02
Drugs
autologous tumor lysate-pulsed dendritic cells
03
Conditions
brain tumorglioblastoma (GBM)
Beyond the preview
Go deeper on NCT00576537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00576537.